The MarketReader Minute
๐ Viking Therapeutics Gains Momentum with New Manufacturing Agreement, Regeneron Faces Market Decline | Biotech Sector Insights
Bank of Canada announced a reduction in its target overnight rate by 25 basis points due to heightened trade tensions from new U.S. tariffs, influencing market sentiment regarding economic stability, which may negatively impact healthcare equities like the iShares Biotechnology ETF (IBB).